Trade Report: The Xylem Inc. (XYL) Receives $46.10 Average Price Target from Analysts

The Xylem Inc. (XYL) Receives $46.10 Average Price Target from Analysts

Xylem Inc. (NYSE:XYL) has received a consensus recommendation of “Hold” from the fifteen research firms that are currently covering the firm. Eight equities research analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $46.10.

A number of analysts have issued reports on the company. RBC Capital Markets set a $51.00 target price on Xylem and gave the company a “buy” rating in a research report on Tuesday, August 16th. Barclays PLC boosted their target price on Xylem from $39.00 to $45.00 and gave the company an “equal weight” rating in a research report on Monday, July 18th. Canaccord Genuity reissued a “hold” rating and issued a $50.00 target price (up previously from $45.00) on shares of Xylem in a research report on Tuesday, August 16th. Zacks Investment Research lowered Xylem from a “buy” rating to a “hold” rating in a research report on Friday, July 15th. Finally, Royal Bank Of Canada boosted their target price on Xylem from $47.00 to $51.00 and gave the company an “outperform” rating in a research report on Tuesday, August 16th.

In other Xylem news, Director Steven R. Loranger sold 32,246 shares of the company’s stock in a transaction on Thursday, July 28th. The shares were sold at an average price of $48.01, for a total value of $1,548,130.46. Following the completion of the transaction, the director now owns 38,334 shares in the company, valued at $1,840,415.34. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Tomas Brannemo sold 8,524 shares of the company’s stock in a transaction on Wednesday, August 17th. The shares were sold at an average price of $50.06, for a total transaction of $426,711.44. The disclosure for this sale can be found here. 0.77% of the stock is currently owned by company insiders.

Institutional investors have recently added to or reduced their stakes in the stock. Advisor Group Inc. bought a new position in Xylem during the second quarter valued at about $100,000. Mizuho Asset Management Co. Ltd. increased its position in Xylem by 122.1% in the second quarter. Mizuho Asset Management Co. Ltd. now owns 2,323 shares of the company’s stock valued at $104,000 after buying an additional 1,277 shares in the last quarter. IFP Advisors Inc increased its position in Xylem by 113.6% in the second quarter. IFP Advisors Inc now owns 2,489 shares of the company’s stock valued at $111,000 after buying an additional 1,324 shares in the last quarter. Northwestern Mutual Wealth Management Co. increased its position in Xylem by 41.2% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 2,699 shares of the company’s stock valued at $120,000 after buying an additional 788 shares in the last quarter. Finally, Glenmede Trust Co. NA increased its position in Xylem by 9.4% in the second quarter. Glenmede Trust Co. NA now owns 2,908 shares of the company’s stock valued at $129,000 after buying an additional 250 shares in the last quarter. Institutional investors own 84.70% of the company’s stock.

Shares of Xylem (NYSE:XYL) opened at 49.47 on Wednesday. The stock’s 50 day moving average price is $50.90 and its 200 day moving average price is $46.46. The stock has a market cap of $8.86 billion, a price-to-earnings ratio of 26.41 and a beta of 1.15. Xylem has a one year low of $31.67 and a one year high of $53.25.

Xylem (NYSE:XYL) last announced its earnings results on Tuesday, August 2nd. The company reported $0.48 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.47 by $0.01. The company had revenue of $932 million for the quarter, compared to analyst estimates of $927.69 million. Xylem had a return on equity of 16.41% and a net margin of 9.22%. The firm’s quarterly revenue was up 1.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.43 earnings per share. Analysts forecast that Xylem will post $2.04 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 7th. Shareholders of record on Wednesday, November 9th will be paid a $0.1549 dividend. The ex-dividend date of this dividend is Monday, November 7th. This represents a $0.62 annualized dividend and a yield of 1.25%. Xylem’s dividend payout ratio is presently 33.16%.

Related posts

Leave a Comment